Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Diagnostics
Sort By
Newest First
1 / 3
1 / 3
Exposomics
Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform
Manish Arora, Ph.D.
LinusBio
PAO-09-24-CL-06
Sep 05, 2024
Neurology
The Next Frontier in Neurological Diagnostics and Therapeutics
Dave Rosa
NeuroOne
PAO-05-24-CL-02
May 30, 2024
Exosomes
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-24-NI-01
May 09, 2024
Point of Care
Expanding Point-of-Care and CME Support for Clinicians
Casey Jenkins
epocrates
PAO-05-23-CL-05
May 03, 2023
Point of Care
Helping Clinicians Make Better Decisions More Easily
Matt Titus
epocrates
PAO-03-23-CL-05
Mar 16, 2023
Digital Health Solutions
Beyond Drug Sales: Adding Value with Digital Health
Gérard Klop; Marcos Gallego Llorente, Ph.D.
PAO-08-022-CL-05
Sep 28, 2022
Theranostics
Theranostic Manufacturing Solutions
Muctarr Sesay, Ph.D.
GBI
PAO-08-022-CL-07
Aug 29, 2022
Genomics
Connecting Genetic Mutations to Health
Heligenics
PAO-03-22-R250-12
Mar 21, 2022
Biosensors
Exploring Living Cells with Fluorescent Biosensors
Montana Molecular
PAO-03-22-R250-15
Mar 19, 2022
Series A Funding
Biofidelity Raises $23M in Series A+ Financing Led by Octopus Ventures to Launch ASPYRE Technology
Biofidelity
PR-M02-22-04
Feb 07, 2022
Diagnostic
GRAIL Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test
GRAIL
PR-M06-21-016
Jun 09, 2021
COVID-19 Diagnostic
FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available Now.
Lucira Health, Inc.
PR-M04-21-016-1029
Apr 16, 2021
Brain Cancer Diagnostics
Advancing Diagnostics to Address Brain Tumors
Dxcover
PAO-04-22-R221-16-538
Apr 09, 2021
Liquid Biopsy
FDA Approves First Liquid Biopsy Next-Generation Sequencing Companion Diagnostic Test
U.S. Food & Drug Administration
PR-M08-20-NI-17
Aug 10, 2020
Diagnostic
New Rapid Molecular Test for Tuberculosis Can Simultaneously Detect Resistance to First- and Second-Line Drugs
Cepheid
PR-M07-20-NI-36
Jul 24, 2020
Coping with COVID-19
COVID-19: Understanding the Virus, the Pandemic, and the Path Forward
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-004
Jul 01, 2020
COVID-19 Testing
The FDA Confirms Certain COVID-19 Serology and Antibody Tests Should Not Be Used
U.S. Food & Drug Administration
PR-M06-20-NI-035
Jun 26, 2020
Diagnostics
Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV
Cepheid
PR-M06-20-NI-024
Jun 18, 2020
Partnership
Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals
Thermo Fisher Scientific
PR-M06-20-NI-023
Jun 18, 2020
COVID-19 Test
FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
U.S. Food & Drug Administration
PR-M05-20-NI-026
May 18, 2020